Over the years, society has changed and thus, the environment. People are now more open to accepting assisted reproductive technology.
Over the years, society has changed and thus, the environment. People are now more open to accepting assisted reproductive technology. Since Louise Brown, the world’s first test-tube baby-assisted reproductive technology has evolved tremendously and offered new, innovative ways to create children. Scientific advancements have changed rapidly the field of assisted reproductive technology, making the procedures more efficient, accessible, more efficient. Over the last few decades, genetic testing and aneuploidy screening has become routine practice to increase the chances of pregnancy.
Download Report Analysis - https://www.alliedmarketresearch.com/request-sample/11359
Assisted reproductive technology commonly refers to Vitro fertilization (IVF), frozen embryo replacement, and artificial insemination. These treatments have proven to be effective for many parents and lead to a healthy birth. However, the parents with the rare hereditary condition still suffer during the pregnancy. However, the recent technological developments are one step further and offer hope to those who suffer from rare health conditions– genetic correction technologies CRISPR and mitochondrial replacement therapy (MRT).
Assisted reproductive technology and CRISPR:
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) means an organization of short partially palindromic repeated DNA sequences that are in the genome of bacteria. This system is used by bacteria to protect themselves from infections. CRISPR offers a new opportunity to treat over 10,000 human diseases and it can be used to eradicate them. This includes some genetic diseases including inherited heart conditions in human embryos.
Assisted reproductive technology and MRT
This technology offers new hope for those women who suffer from mitochondrial diseases but wish to become pregnant. MRT can be used to replace the mitochondria in the egg of Leigh syndrome patients. This syndrome refers to a severe neurological condition and leads to loss of mental and movement abilities that ultimately leads to death. The patients who suffer from undiagnosed pregnancy losses can take the help of this technology and have a healthy pregnancy with a few follow-up check-ups to determine the long-term impact on the offspring.
According to Allied Market Research, the global Assisted Reproductive Technology Market is expected to reach $12.27 billion by 2030, growing at a CAGR of 19.3% from 2021 to 2030. Rise in the prevalence of infertility rate, surge in disposable income and awareness regarding infertility treatment, and technological advancements in assisted reproductive technology have boosted the market growth. The increased research and implementation of MRT and CRISPR have opened new opportunities in the assisted reproductive technology field and hope to those who wish for a healthy pregnancy.